-
Novan (NOVN) to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
-
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
-
Lemelson Capital Comments on Ligand Pharmaceuticals (LGND) Going Concern Risk
-
Unusual 11 Mid-Day Movers 11/08: (RJET) (MSSR) (DYN) Higher; (TRGT) (XIDE) (LGND) Lower
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma

